Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar ztur2218 (< 20) Submitted: 3/6/2011 8:58:47 AM : Outperform Start Price: $2.35 ASTM Score: -12.19

risk

Featured Broker Partners


Advertisement